ArticleOncology and therapy2023

Shared Decision-Making on Using a CDK4/6 Inhibitor plus an Aromatase Inhibitor for HR+/HER2- Metastatic Breast Cancer: A Podcast.

Brian Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.